January 13-16, 2025 | San Francisco Marriott Marquis & Virtual

Participating Companies

orange background

Loading

All
0 - 9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Letter
- G

GAIA AG

United States

Biotech or pharma, therapeutic R&D

Digital health
GEM NY_Sam Boyle

United States

Investor (buy-side or sell-side research)

Other products or services
Global Emerging Markets Group_Ashita Katiyar

United States

Individual Investor
Global Emerging Markets Group_Lucas Obrycki

United States

Individual Investor
GreenSky Ventures

Canada

VC/Corporate VC
Genomenon

United States

Digital health

IT, information

Medical device or technology

Other R&D services
GenScript USA Inc.

United States

Biotech or pharma, therapeutic R&D
Glycyx MOR, Inc.

United States

Biotech or pharma, therapeutic R&D
Glyscend Therapeutics

United States

Biotech or pharma, therapeutic R&D
Genescience Pharmaceuticals Co., Ltd

United States

Biotech or pharma, therapeutic R&D
Genesys Capital Partners Inc.

Canada

VC/Corporate VC
Genfit SA

France

Biotech or pharma, therapeutic R&D
GENZEVA

United States

Biotech or pharma, therapeutic R&D
GrekTek

United States

Digital health

Medical device or technology
General Inception

United States

VC/Corporate VC
Guangzhou Magpie Pharmaceuticals CO., LTD.

China

Biotech or pharma, therapeutic R&D
Grant Engine

United States

Angel Investing
Globescape Capital, Inc

United States

VC/Corporate VC
General Proximity

Biotech or pharma, therapeutic R&D
Gritgen Therapeutics Co., Ltd.

China

Biotech or pharma, therapeutic R&D
GenEdit

United States

Biotech or pharma, therapeutic R&D

Loading

Loading